News

Fresh analysis of data on Novartis’ Gilenya and Sanofi/Genzyme’s Lemtrada back their long-term efficacy in keeping multiple sclerosis at bay.

Use of a high sensitivity blood test in A&E departments across the country could rule out heart attack in two thirds of people presenting with chest pain, a new study funded by Edinburgh University has found.

Some patients with advanced skin cancer will now be able to get routine access to Merck, Sharp & Dohme’s immunotherapy Keytruda on the National Health Service in England and Wales, after cost regulators issued final guidance endorsing its use within a restricted population.

New research from the UK has revealed huge gaps in public knowledge of mesothelioma, with near 70% of people surveyed not able to name even one symptom of the disease.

The risk of stroke is significantly reduced for up to two months after receiving a flu vaccine, according to a new study.

UK-based life sciences group Horizon Discovery has in-licensed a novel kinase inhibitor programme from France’s Servier in a deal that could potentially add more than £50 million to its books.

Merck and Pfizer’s investigational immunotherapy avelumab has been granted Fast Track designation in the US in a move designed to accelerate its development for a rare and aggressive skin cancer called metastatic Merkel cell carcinoma.

The US Food and Drug Administration will undertake a speedy review of three supplemental marketing applications for Bristol-Myers Squibb’s hepatitis C drug Daklinza, which, if successful, could significantly expand the drug’s scope in difficult-to-treat subpopulations.

US regulators have approved a new long-acting, injectable antipsychotic with a range of dosing strengths and regimens designed to address the individual treatment needs of patients with schizophrenia.

Merck & Co’s investigational single-tablet hepatitis C combination therapy elbasvir/grazoprevir has shown promise in the treatment of patients who also have advanced kidney disease, including those on dialysis.

A new report is estimating that as many as one in four GP appointments across England could be avoided through a shake-up of operations that would reduce bureaucracy and maximise resources.

Three researchers have been awarded the Nobel Prize for Medicine for their pioneering work on therapies targeting the parasitic diseases river blindness and malaria.

The UK’s end of life care has been named the best in the world in a new Economist Intelligence Unit report.

Bristol-Myers Squibb has agreed to pay more than $14 million to settle US Securities and Exchange Commission charges over acts of bribery in China.

Prime minister David Cameron has announced a new voluntary contract for GPs that will extend their services to seven days a week.